
OM · NASDAQ
Outset Medical, Inc.
$4.43 +0.30 (+7.23%)
Company overview
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $83.3M
- Employees
- 354
- Headquarters
- San Jose, CA
- Website
- outsetmedical.com
- CEO
- Leslie L. Trigg
- Listed
- September 15, 2020
- P/E
- -1.06
- Dividend yield
- 0.00%
Company financials
- Revenue
- $118M
- Gross profit
- $47.8M
- Operating income
- -$66.9M
- EBITDA
- -$62.7M
- Net income
- -$74.8M
- EPS
- -$4.16
- Total assets
- $249M
- Total debt
- $4.7M
- Gross margin
- 40.64%
- Net margin
- -63.65%
- Earnings yield
- -93.91%
No geographic segmentation.
Showing FY 2025
News